Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · prior close shown (market closed)
Limited proprietary earnings coverage for CNTA yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 79d ago
CNTA's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on CNTA.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for Centessa Pharmaceuticals plc (CNTA) — events, not interpretation.
Research & analysis only — not investment advice.
AlphaOS industries
Investment snapshot
CNTA's AI investment thesis
Upgrade to Premium for CNTA's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Prior close
$40.50
Market cap
$6.27B
Profitable
No
Revenue $15.00M
Net income
$-197.53M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Centessa Pharmaceuticals plc — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Centessa Pharmaceuticals plc through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.